{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "AXTI",
  "name": "AXT Inc",
  "url": "https://orbyd.app/dossiers/AXTI/",
  "json_url": "https://orbyd.app/dossiers/AXTI.json",
  "status": "WATCHLIST",
  "current_conviction": "MEDIUM",
  "graded_conviction": null,
  "archetype": {
    "code": "a2",
    "n": 2
  },
  "current_thesis": "InP scarcity went sector-wide on 2026-08-06 (TrendForce, quoting Lumentum's CEO on a >30% supply gap \"worse than memory\"), and AXTI ran $68.61 to $88.58 into 2026-08-07 (+17.84% on 19.0M shares), reclaiming the 50-day at $72.41. Lumentum 08-11 and Coherent 08-12 are the demand-side check on the ~$66M Q3 guide, now against 45x sales.",
  "invalidation_trigger": "A weekly close below $68 gives back the entire 2026-08-05 to 2026-08-07 expansion leg, losing the 2026-08-03 close of $68.67 and the rising 50-day moving average near $72.41. Secondary: Lumentum (2026-08-11) or Coherent (2026-08-12) guiding datacom below consensus, or the initial $43.5M Lumentum deposit not landing by ~2026-09-04.",
  "catalyst_date": "2026-08-11",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "networking-optical",
    "ai-datacenter-infrastructure",
    "ai-chips-memory",
    "semi-foundry-equipment"
  ],
  "tags": [
    "watchlist"
  ],
  "sources": [],
  "notes": [
    "2026-04-18: seed: Serenity/attention list",
    "Squeeze leg complete. NO CHASE.",
    "2026-04-20: Q1 pre-announced $26-28M rev / -$0.03 to -$0.05 EPS — 2026-05-06 print is de-risked AND neutralized as upside catalyst.",
    "2026-06-05: Structure broke — closed ~$89.04 (-15.99%, range $83.15-$104.55), losing the $90 base that was the prior abort line. Driver: CEO Morris Young disclosed >$22M insider sale + valuation/AI-semi-group selloff. -38% off the $143.16 ATH (5/26) in ~7 sessions. Second management top-tick after the $64.25 secondary (8.56M sh, 4/21).",
    "Consolidated raw-material joint ventures sit inside reported revenue - $10.0M of the $47.6M Q2 2026 total - and carry minority interests; GAAP net income is stated after those interests.",
    "Tongmei withdrew its STAR Market application 2026-06-26 and describes a Hong Kong listing as roughly a one-year path; a ~$49M (RMB 324.4M) 2021 PE redemption right was triggered.",
    "Authorized common stock was raised from 70,000,000 to 120,000,000 shares effective 2026-06-04, against 63.82M shares outstanding - large unissued issuance headroom.",
    "A bylaw amendment approved 2026-07-26 cut the shareholder-meeting quorum from a majority to 33 1/3%, after the May 2026 annual meeting adjourned for want of a quorum.",
    "Single-stock leveraged ETFs track AXTI and moved as much as 49% on 2026-07-31 against a 28.74% move in the shares, adding mechanical end-of-day flow.",
    "Management models China at 40-60% of revenue; per the 2026-07-30 call, permit timing and approval beyond already-cleared product cannot be forecast."
  ],
  "body_markdown": "## Current Thesis\n\nThe contested reclaim from 2026-08-04 resolved upward, and quickly. The Friday close sits just beneath the 2026-06-05 breakdown close of $89.04 and back above the 50-day moving average, $72.41 as of 2026-08-09, with the 200-day at $48.46.\n\nThe leg on offer is unchanged in substance: a customer-funded indium-phosphide capacity ramp one layer upstream of the 800G/1.6T optical interconnect build. What changed in the week of 2026-08-03 is the frame around it. On 2026-08-06 TrendForce carried Lumentum CEO Michael Hurlston describing the InP supply-demand gap as now wider than DRAM and NAND, with the shortfall above 30%. A single-company earnings beat on 2026-07-30 became an industry-level scarcity story six sessions later, and the bid widened accordingly.\n\nTwo of the three counterparties that signed capacity commitments report inside 72 hours of this note — Lumentum after the close 2026-08-11, Coherent after the close 2026-08-12. Both are the demand-side check on the ~$66M Q3 guide.\n\n## Bull Case\n\n- **Q2 2026, reported 2026-07-30:** revenue $47.6M against $34.1M consensus, versus $18.0M in Q2 2025 and $26.9M in Q1 2026. GAAP gross margin 44.9% against 29.6% in Q1. Non-GAAP net income $11.9M, $0.19 per share, against $0.07 estimated. InP revenue $30.7M — the highest quarterly InP figure the company has recorded.\n- **Q3 2026 guide ~$66.0M** versus a $38.8M Street figure, non-GAAP EPS $0.30–$0.32 against $0.11. On the 2026-07-30 call management said the number rests on export permits already granted or on product outside the restricted set, so the Chinese licensing variable that constrained Q4 2025 is pre-cleared for one quarter.\n- **Three committed agreements in seven weeks.** Casela: Tongmei signed 2026-06-11 for a fixed CY2027 InP quantity at RMB 173,000,000 (~$25.4M). Coherent: three-year 6-inch InP master development and supply agreement effective 2026-06-25 with a $22.3M prepayment (8-K filed 2026-07-02). Lumentum: Capacity Reservation Agreement entered 2026-07-26 (8-K filed 2026-07-29) — initial deposit $43,500,000 due within 30 business days, a second $43,500,000 with terms set during CY2028, against a six-year minimum commitment.\n- **Backlog above $100M** per the 2026-07-30 call, with a stated capacity path of ~$60M/quarter of InP exiting 2026 and ~$130M/quarter exiting 2027. Cash and investments $749M at 2026-06-30 against $123M at 2026-03-31; inventory $96.3M, up ~$6.2M in the quarter.\n- **Third-party corroboration of the constraint, 2026-08-06:** the TrendForce piece attributes to Lumentum's CEO a supply gap exceeding memory's, the first sector-level datapoint on this bottleneck that does not originate with AXT management or its sell-side coverage.\n- **Sell-side reset 2026-07-30/31:** five-analyst mean target $91.6 (3 Strong Buy / 2 Hold) — Northland $125, Wedbush $93, Needham $90 on an upgrade from Hold, B. Riley $55 Neutral with the target raised. BlackRock disclosed 4,653,059 shares, 7.1% of class, in a Schedule 13G filed 2026-07-27.\n\n## Bear Case\n\n- **Price has closed the gap to the consensus target.** The $88.58 close on 2026-08-07 sits against a five-analyst mean of $91.6 struck on 2026-07-30/31, and above four of the five published targets other than Northland's $125. Further upside now requires target revisions rather than target convergence.\n- **The multiple re-rated with the price.** P/S 45.04 and EV/sales 42.39 as of 2026-08-09, against 33.19 and 30.54 at the 2026-08-04 close, on a $5.65B market cap and $47.6M of quarterly revenue. Forward P/E 55.85.\n- **The prepayments are refundable liabilities.** Coherent's $22.3M is refundable at Coherent's option if unused at expiry or termination; the Lumentum deposits are refundable on an uncured capacity failure, and the agreement is terminable if AXT misses its capacity commitment for more than six consecutive months.\n- **Corporate and insider supply has met strength twice.** 8,560,311 shares priced at $64.25 in the April secondary; CEO Morris Young disclosed sales above $22M ahead of the 2026-06-05 breakdown from ~$89. Authorized common was raised from 70,000,000 to 120,000,000 shares effective 2026-06-04 against 63.82M outstanding.\n- **The short base has not been re-measured.** 11.02M shares short, 18.27% of a 60.31M float, 1.11 days to cover — on a settlement date that predates the 2026-07-30 through 2026-08-07 sessions entirely. How much of the move off the 2026-08-03 low of $53.66 was covering is unknown until the report covering the 07-31 settlement lands.\n- **China concentration is unforecastable by management's own account.** The 2026-07-30 call put China at 40–60% of revenue and stated that permit timing and approval beyond already-cleared product cannot be forecast.\n\n## Setup & Price Structure\n\nLife-cycle: **ACCELERATING**, dated to 2026-08-06 and 2026-08-07. The 2026-08-06 TrendForce item moved the story from AXT's own print to a named third-party shortage claim, and 2026-08-07 traded +17.84% to $88.58 on 19.01M shares — volume expanding again after 13.51M and 11.22M on the two prior sessions. Fresh attention plus expanding participation is the accelerating signature, on top of a 2026-07-31 Needham upgrade to Buy and a 2026-07-31 B. Riley target raise. The counter-reading is that the label has a short half-life in this name: the same stock printed $143.16 in late May and $53.66 intraday on 2026-08-03.\n\nStructure: the 2026-08-03 low of $53.66 and the $68.67 / $68.61 closes on 08-03 and 08-05 form the base of the current leg. The April secondary price of $64.25 now sits beneath that base rather than at it. Overhead, the 2026-06-05 close of $89.04 and the 2026-08-07 high of $89.49 mark the first shelf; the May peak at $143.16 is the outer reference.\n\nCrowding and positioning observables: price closed $88.58 against a 50-day of $72.41 and a 200-day of $48.46; short interest of 11.02M shares was last measured on a settlement predating the whole move; single-stock leveraged ETFs tracking AXTI moved as much as 49% on 2026-07-31 against a 28.74% move in the shares, which concentrates mechanical rebalancing flow at the close; retail-facing coverage clustered heavily in the 2026-07-31 to 2026-08-07 window (multiple Benzinga movers items, a \"$1,000 invested 15 years ago\" piece on 2026-08-04). No earnings date is imminent — the print already happened on 2026-07-30 — so the near-term binaries belong to other companies' calls.\n\n## Catalyst Calendar (next 30 days)\n\n- **~2026-08-10 (est.)** — Q2 2026 Form 10-Q. First look at how the Casela and Coherent commitments are carried, customer-deposit and deferred-revenue balances, capex against the capacity plan, the composition of $96.3M of inventory, and the Tongmei redemption-right language. The Lumentum agreement is not included; the 8-K states it will be filed with the Q3 10-Q.\n- **2026-08-11** — Lumentum FQ4 FY2026 results, after close. The counterparty on a six-year InP reservation reports sixteen days after entering it, and its CEO is the source of the 2026-08-06 shortage claim.\n- **~2026-08-12 (est.)** — FINRA short-interest report covering the 2026-07-31 settlement. First positioning read spanning the 07-30 and 07-31 gap sessions.\n- **2026-08-12** — Coherent FQ4 FY2026 results for the quarter ended 2026-06-30, after close. The other prepaying customer; transceiver volume guidance reads directly onto the ~$66M Q3 figure.\n- **~2026-08-26 (est.)** — NVIDIA FQ2 FY2027 results. Sets the demand tone for the interconnect build the entire InP backlog is levered to.\n- **~2026-09-04 (est.)** — Lumentum initial $43,500,000 deposit falls due, 30 business days from the 2026-07-26 entry. Receipt converts a signed reservation into funded balance-sheet cash.\n\n## What Would Change Our Mind\n\nThe structure that matters is the base built between 2026-08-03 and 2026-08-05, not the highs. Giving back the entire three-session expansion leg — a **weekly close below $68**, losing the 2026-08-03 close of $68.67 and the 2026-08-05 close of $68.61 and returning price beneath the 50-day at $72.41 — would say the 2026-08-06 shortage headline bought three days of attention and no durable holders.\n\nSecond, the counterparty prints. Lumentum on 2026-08-11 or Coherent on 2026-08-12 guiding datacom below consensus, or declining to corroborate substrate tightness on the call, would break the third-party leg of the story while AXT's own guide stays intact for one more quarter.\n\nThird, the funding proof. If the initial $43,500,000 Lumentum deposit has not landed by roughly 2026-09-04, that is the first slip in three agreements signed inside seven weeks, and the distance between a signed reservation and received cash becomes the whole argument.\n\nFourth, supply into strength. New Form 4 sales at post-run prices, or a shelf takedown or ATM disclosure in the Q2 10-Q despite $749M of cash and investments, would repeat the pattern set by the $64.25 April secondary and the June insider sales.\n\nIf instead coverage broadens to mainstream while price stalls under the 2026-08-07 high of $89.49 on falling volume, the correct label becomes SATURATED and the accelerating read is spent.\n\n## Correlation Notes\n\n- **Direct counterparties:** LITE (reports 2026-08-11) and COHR (2026-08-12) are both customers and, in Lumentum's case, an InP producer in its own right — its capacity commentary cuts both ways for AXT.\n- **Demand tone:** NVDA (~2026-08-26) sets the interconnect capex frame; optical module and transceiver names trade as the second derivative of the same order book.\n- **Mechanical flow:** single-stock leveraged ETFs tracking AXTI amplified the 2026-07-31 move to as much as 49% against 28.74% in the underlying, which concentrates flow into the closing auction on trend days in either direction.\n- **Policy:** Chinese export-permit policy on gallium and related materials is the shared risk factor across the compound-semiconductor substrate complex; management put China at 40–60% of revenue on 2026-07-30 and declined to forecast permit timing beyond already-cleared product.\n- **Analogue:** the \"worse than memory\" framing attributed to Lumentum's CEO on 2026-08-06 links this narrative to the DRAM/NAND shortage trade, so memory-cycle sentiment now bleeds into how the InP story is priced.",
  "first_seen": "2026-04-19",
  "last_analyzed": "2026-08-09T10:37:30+00:00",
  "last_synthesized": "2026-08-09",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}